Karyopharm Therapeutics Inc. buy Royal Bank of Canada
Start price
13.05.25
/
50%
€0.54
Target price
13.05.26
€29.71
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 13.05.26. The prediction end date can be changed by Royal_Bank_of_Canada at any time.Performance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Karyopharm Therapeutics Inc. | - | - |
| iShares Core DAX® | 0.648% | 1.259% |
| iShares Nasdaq 100 | -0.034% | 2.797% |
| iShares Nikkei 225® | 2.445% | 9.854% |
| iShares S&P 500 | 0.492% | 2.570% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Karyopharm Therapeutics Inc. diskutieren
Karyopharm Therapeutics Inc. (NASDAQ: KPTI) had its price target lowered by analysts at Royal Bank of Canada from $34.00 to $33.00. They now have an "outperform" rating on the stock.
Ratings data for KPTI provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for Karyopharm Therapeutics Inc.
Karyopharm Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.59
20.02.25
20.02.25
€2.86
20.02.26
20.02.26
-6.32%
25.02.25
25.02.25
Karyopharm Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.61
10.02.25
10.02.25
€2.91
10.02.26
10.02.26
-9.57%
25.02.25
25.02.25
Karyopharm Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.72
07.08.24
07.08.24
€2.75
07.08.25
07.08.25
-25.10%
08.08.25
08.08.25
Karyopharm Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.84
03.11.23
03.11.23
€2.80
03.11.24
03.11.24
-1.41%
04.11.24
04.11.24
Karyopharm Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.67
03.08.23
03.08.23
€3.65
03.08.24
03.08.24
-54.66%
04.08.24
04.08.24